10x Genomics Inc - Ordinary Shares - Class A
News
Lausanne Researchers Combine 10x Genomics' Chromium and Xenium for Novel Insights into Resistance and Potential Therapeutics for Brain Cancer
PR Newswire Lausanne Researchers Combine 10x Genomics' Chromium and Xenium for Novel Insights into Resistance and Potential Therapeutics for Brain Cancer Lausanne Researchers Combine 10x Genomics' Chromium and...\n more…
We're Interested To See How 10x Genomics (NASDAQ:TXG) Uses Its Cash Hoard To Grow
Simply Wall St Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...\n more…
North Star Asset Management Inc. Buys 9,514 Shares of 10x Genomics, Inc. (NASDAQ:TXG)
Ticker Report North Star Asset Management Inc. raised its stake in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 21.8% during the 2nd quarter, according to its most recent filing with the Securities...\n more…
10x Genomics (NASDAQ:TXG) Given "Overweight" Rating at Stephens
Ticker Report 10x Genomics (NASDAQ:TXG - Get Free Report)s stock had its "overweight" rating reissued by investment analysts at Stephens in a research report issued to clients and investors on Wednesday...\n more…
Brokers Set Expectations for 10x Genomics, Inc.'s Q3 2024 Earnings (NASDAQ:TXG)
Ticker Report 10x Genomics, Inc. (NASDAQ:TXG - Free Report) - Research analysts at Leerink Partnrs issued their Q3 2024 earnings per share estimates for 10x Genomics in a research report issued to clients and...\n more…
Research Analysts Offer Predictions for 10x Genomics, Inc.'s Q3 2024 Earnings (NASDAQ:TXG)
Zolmax 10x Genomics, Inc. (NASDAQ:TXG - Free Report) - Research analysts at Leerink Partnrs issued their Q3 2024 EPS estimates for shares of 10x Genomics in a report released on Tuesday, September 3rd...\n more…